SCHEMBL19923697

SCHEMBL19923697

CC(C)[Si](C(C)C)(C(C)C)N1C(=O)N(Cc2ccccc2)C(=O)C1(Cc1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.45
CYP2C19 P33261 4/20 0.42
ELANE P08246 4/20 0.42
CTSG P08311 2/20 0.41
F2 P00734 1/20 0.41
PLG P00747 1/20 0.41
CMA1 P23946 1/20 0.41
CTRC Q99895 1/20 0.41
ATM Q13315 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PRTN3 P24158 1/20 0.38
LMNA P02545 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
MGLL Q99685 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923421 0.86 NPSR1 (0.48) NPSR1CYP2C19ELANECTSGF2
SCHEMBL19923723 0.84 NPSR1 (0.49) NPSR1CYP2C19ELANECTSGF2
SCHEMBL19923604 0.82 ELANE (0.48) NPSR1CYP2C19ELANECTSGF2
SCHEMBL19923611 0.82 NPSR1 (0.43) NPSR1CYP2C19ELANECTSGF2
SCHEMBL19923719 0.80 NPSR1 (0.51) NPSR1CYP2C19ELANECTSGF2
SCHEMBL19923672 0.72 KMT2A (0.40) NPSR1CYP2C19ELANEATMMEN1
SCHEMBL19923755 0.70 NPSR1 (0.59) NPSR1CYP2C19ELANECTSGF2
SCHEMBL19923703 0.69 ELANE (0.51) NPSR1CYP2C19ELANECTSGF2
SCHEMBL19923556 0.69 ELANE (0.48) NPSR1ELANEMEN1KMT2ALMNA
SCHEMBL17716262 0.68 NPSR1 (0.74) NPSR1ELANECTSGF2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN NPSR1 1322/4885CYP2C19 1347/4885ELANE 1249/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM NPSR1 1281/4885CYP2C19 1259/4885ELANE 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.